MedPath

Training of Neural Responding in BPD

Not Applicable
Conditions
F60.31
Registration Number
DRKS00009363
Lead Sponsor
Department of Psychosomatic Medicine and Psychotherapy, Central Institute of Mental Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
25
Inclusion Criteria

Current BPD (= 4 DSM-V criteria), female, informed consent for study participation

Exclusion Criteria

Psychotropic medication with tranquilizers, lifetime diagnosis of schizophrenia or bipolar I, substance dependence in the preceding year, current substance use, pregnancy, epilepsy, antecedent cranial or brain injuries, organic brain diseases, severe medical or neurological condition, BMI<16.5, metallic non-removable items in or on the body which are not MR compatible, permanent make-up, claustrophobia, left-handedness

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Target criterion: Improvement of emotion regulation. Measures: Questionnaire: Difficulties in Emotion Regulation Scale (DERS); Peripheral physiologic measures: Fear-potentiated startle with instructed emotion regulation vs. natural responding to emotional pictures, heart rate variability (relation of high vs. low frequencies in spectrum). Central nervous system measures: amygdala BOLD response to masked affective facial expressions, amygdala BOLD response in Sternberg-Working Memory test with emotional vs. neutral distractor images. Acquisition times: T0: Treatment group: max 7 days before first training session (depends on patient's availability), T1: max 7 days after third training session, T2 (Follow up): 6 weeks after T1
Secondary Outcome Measures
NameTimeMethod
Target criterion: Reduction of BPD symptom severity. Measures: ZAN-BPD structured interview (acquisition in T0 and T2), BSL-23 self-report questionnaire (acquisition in T0, T1, T2; time lag matched to treatment group).
© Copyright 2025. All Rights Reserved by MedPath